|
Publications
-
06.04.2021Updates on the Implementation of the Newly Amended PRC Patent LawUpdatesThe China National Intellectual Property Administration and the National Medical Products Administration in the People’s Republic of China issued measures to facilitate the implementation of the newly amended PRC Patent Law.
-
05.13.2021Three Changes to Pharmaceutical Patents in the PRCUpdatesThis update addresses three important changes to pharmaceutical patents in the People's Republic of China (PRC) in view of the newly amended PRC Patent Law, which will take effect on June 1, 2021, and the recent amendments to the Patent Examination Guidelines that took effect on January 15, 2021. These changes aim to improve patent protection and enhance patent value for inventions in the PRC; they are also consistent with matters addressed in the Economic And Trade Agreement Between the Government of the United States of America and the Government of the People’s Republic of China.
-
10.22.2019Two Paths for Accelerating Patent Prosecution in ChinaUpdatesIn recent years, with the increase in patent applications filed in China, the China National Intellectual Property Administration (CNIPA) has focused on expediting patent examinations to decrease the duration of the normal patent prosecution process.
-
09.03.2014Immunizing Patent Portfolios Against “Infectious” EstoppelUpdatesParties challenging patents under the post-issuance review proceedings authorized by the America Invents Act have long worried about estoppel in later district court cases if they lose before the Patent Trial and Appeal Board (PTAB).
-
10.06.2009Bd. of Trs. of the Leland Stanford Junior Univ. v. Roche Molecular Sys.: Federal Circuit Rules on Timing of Patent Assignment Clause in an Employment AgreementUpdatesOn October 1, 2009, the Federal Circuit issued an opinion in Stanford v. Roche, Case Nos. 2008-1509, 2008-1510. One section addresses the interpretation of a patent assignment clause to determine whether it creates an automatic assignment or merely an obligation to assign.
-
02.04.2006Transcriptional Inhibition by an Oxidized Abasic Site in DNAArticles
American Chemical Society
-
11.19.2003Chemoenzymatic Synthesis and Antibody Detection of DNA GlycoconjugatesArticles
American Chemical Society
Presentations
-
07.01.2022Guangdong Overseas Intellectual Property Protection Training ProgramSpeaking Engagements2022 Guangdong Overseas IP Protection Training Program / Guangdong, China
Five Perkins Coie Intellectual Property partners were recently invited to present at the 2022 Guangdong Overseas IP Protection Training Program. The program is a series of courses that is designed for IP professionals in Guangdong.
-
09.14.2021Intellectual Property Protection of Integrated CircuitsSpeaking EngagementsSchool of Microelectronics, Shanghai University / Shanghai, ChinaPerkins Coie’s patent team in Shanghai was invited to provide a patent training at the Shanghai University.
-
07.21.2021Generic v. Branded: Patent Linkage in China v. USSpeaking Engagements
China Intellectual Property Forum / Shanghai, China
China IP Legal Report Blog
-
CNIPA Issues Significant Draft Amendment to the PRC Trademark Law
On January 13, the China National Intellectual Property Administration (CNIPA) circulated a draft amendment to the PRC Trademark Law for public comment (“TML Draft Amendment”). The TML Draft Amendment is the product of deliberations that officially commenced in 2018. This deliberation process resulted in the 2019 stop-gap revisions to the Trademark Law that were primarily focused... Continue Reading…
-
On December 29, 2021, the Beijing Intellectual Property Court (the Court) maintained the validity of CN Invention Patent No. ZL200680025545.1 (the ’545 patent), which reversed an invalidation decision[1] made by the Patent Reexamination and Invalidation Department of the China National Intellectual Property Administration (CNIPA). The Court held that the claimed invention is inventive because one... Continue Reading…
-
The Patent Reexamination and Invalidation Department (PRID) of the China National Intellectual Property Administration (CNIPA) invalidated the CN Invention Patent No. 201310567987.0 (the ’987 patent)[1] because the patentee failed to submit a request for grace period for a novelty art (“the Request”) within two months after the patentee knew or should have known about the... Continue Reading…
-
The Patent Reexamination and Invalidation Department (PRID) of the China National Intellectual Property Administration (CNIPA) maintained the validity of CN Invention Patent No. ZL02123000.5 (the ’000 patent) in an invalidation proceeding.[1] The PRID held that the claimed invention is inventive because: (1) one person of ordinary skill in the art would not have been motivated to... Continue Reading…
